Author:
Polat Mehmet,Polat Hurriyet
Reference187 articles.
1. Afkham A, Aghebati-Maleki L, Siahmansouric H, Sadreddini S, Ahmadia M, Dolati S, Jadidi-Niaragh F, Yousefi M, Siahmansouri H, Afkham NM, Akbarzadeh P, Yousefib M et al (2018) Chitosan (CMD)-mediated co-delivery of SN38 and Snail-specific siRNA as a useful anticancer approach against prostate cancer. Pharmacol Rep 70:418–425
2. Ahmad FJ, Islam F, Alam S, Mustafa G, Bhatnagar A, Khan ZI et al (2012) Development and evaluation of thymoquinone encapsulated chitosan nanoparticles for nose-to-brain targeting: a pharmaco scintigraphic study. Int J Nanomed 7:5705–5718
3. Ahsan SM, Thomas M, Reddy K, Sooraparaju SG, Asthana A, Bhatnagar I et al (2018) Chitosan as biomaterial in drug delivery and tissue engineering. Int J Boil Macromol 110:97–109
4. Alam S, Khan ZI, Mustafa G, Kumar M et al (2012) Development and evaluation of thymoquinone-encapsulated chitosan nanoparticles for nose-to-brain targeting: a pharmacoscintigraphic study. Int J Nanomedicine 7:5705–5718
5. Ali A, Ahmed S et al (2018) A review on chitosan and its nanocomposites in drug delivery. Int J Biol Macromol 109:273–286